Is this email not displaying correctly? View it in your browser.
Newswise - News for JournalistsNewswise - pix
Newswise Special Wire
Tuesday, August 18, 2020

Public edition |

Newswise Cancer Research Wire for


Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.

Acidic Niche Keeps Lymphatic System in Check during Immune Response, Moffitt Researchers Say

In a new article published in Nature Communications, Moffitt Cancer Center researchers describe a novel acidic niche within lymph nodes that plays an integral role in regulating T cell activation.

– Moffitt Cancer Center

Nature Communications, Aug-2020

Half of breast cancer survivors had delays in care due to COVID-19

The results of an online questionnaire of 609 breast cancer survivors in the U.S. suggest that nearly half of patients experienced delays in care during the early weeks of the COVID-19 pandemic. The study, by researchers at the University of Illinois...

– University of Illinois at Chicago

Breast Cancer Research and Treatment

Structure of a Complex Enzyme That Protects Cells From DNA Damage Is Uncovered by Mount Sinai Researchers

A research team from Mount Sinai has unraveled for the first time the three-dimensional structure and mechanism of a complex enzyme that protects cells from constant DNA damage, opening the door to discovery of new therapeutics for the treatment of c...

– Mount Sinai Health System

Nature Structural & Molecular Biology, Aug-2020

Embargo expired on 17-Aug-2020 at 11:00 ET

Targeted therapy combination effective for patients with advanced cholangiocarcinoma and BRAF mutations

In a Phase II trial led by MD Anderson researchers, a combination targeted therapy acheived a 51% overall response rate in patients with cholangiocarcinoma and BRAF V600E mutations. This is the first prospective study for this group of patients.

– University of Texas M. D. Anderson Cancer Center

Lancet Oncology

Embargo expired on 17-Aug-2020 at 18:30 ET

Live Press Conference: Immunotherapy extends survival in mouse model of hard-to-treat breast cancer (video)

A press conference on this topic will be held Tuesday, Aug. 17, at 10 a.m. Eastern time online at

– American Chemical Society (ACS)

ACS Fall 2020 Virtual Meeting & Expo Press Center

Extrachromosomal DNA is common in human cancer and drives poor patients outcomes

The multiplication of genes located in extrachromosomal DNA that have the potential to cause cancer drives poor patient outcomes across many cancer types, according to a Nature Genetics study published Aug. 17, 2020 by a team of researchers including...

– University of California San Diego

Nature Genetics

Why Young and Female Patients Don’t Respond as Well to Cancer Immunotherapy

UC San Diego researchers discovered that tumor cells in younger and female patients accumulate cancer-causing mutations that are more poorly presented to the immune system, better enabling tumors to escape detection and clearance.

– University of California San Diego Health

Nature Communications

Potency-enhancing drugs linked to decreased risks in men with colorectal cancer

A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer. PDE5 inhibitors include a f...

– Lund University

Nature Communications

What Does it Mean to be An NCI-Designated Comprehensive Cancer Center?

Rutgers Cancer Institute is a National Cancer Institute-designated Comprehensive Cancer Center, a designation reserved for those cancer centers who meet the highest of standards in research, treatment, prevention and education. Rutgers Cancer Institu...

Expert Available

– Rutgers Cancer Institute of New Jersey

PARP inhibitor becomes new treatment option for some men with advanced prostate cancer

Results from an international clinical trial found that men with advanced prostate cancer who have mutated BRCA1/BRCA2 genes can be treated successfully with a targeted therapy known as rucaparib.

– University of Chicago Medical Center

Journal of Clinical Oncology

Embargo expired on 14-Aug-2020 at 16:00 ET

“Multitasking” AI Tool Extracts Cancer Data in Record Time

Digital cancer registries collect, manage, and store data on cancer patients to help identify trends in diagnoses and treatment. However, cancer pathology reports are complex. To better leverage data, scientists developed an artificial intelligence-b...

– Department of Energy, Office of Science

Study Suggests New Potential Approach Against Fatal Childhood Brain Cancer

In mouse models of DIPG, simultaneously attacking two metabolic pathways led to significant improvements in survival.

– Michigan Medicine - University of Michigan

Cancer Cell

Flipping a metabolic switch to slow tumor growth

The enzyme serine palmitoyl-transferase can be used as a metabolically responsive “switch” that decreases tumor growth, according to a new study by a team of San Diego scientists, who published their findings Aug. 12 in the journal Nature. By ...

– University of California San Diego

Nature; New England Journal of Medicine

Rutgers Cancer Institute Researchers Utilize 4D Printing with Patient Derived Organoids to Accelerate Treatment Testing for Common Brain Tumor

Rutgers Cancer Institute investigator shares about a new project in which 4-dimensional (4D) printing of arrays that transform from cell-culture inserts into histological cassettes are utilized and hold patient tissue samples for rapid programmable d...

– Rutgers Cancer Institute of New Jersey


Some physicians are ordering thyroid tests for unsupported reasons

Up to one-third of physicians reported sending patients for a thyroid ultrasound for reasons not supported by clinical care guidelines, a new study led by University of Michigan Rogel Cancer Center researchers finds. Routine use of ultrasounds to det...

– Michigan Medicine - University of Michigan

JAMA Surgery; CA201198; HS024512 ; T32DK07245

Combination therapy significantly improves survival outcomes for patients with acute myeloid leukemia

A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD A...

– University of Texas M. D. Anderson Cancer Center

New England Journal of Medicine; 25th European Hematology Association (EHA) Annual Congress

Prostate Cancer Treatment Might Help Some Glioblastoma Patients

Anti-androgen therapy showed positive results in cell lines and animal models against glioblastoma, an aggressive form of brain cancer.

– Michigan Medicine - University of Michigan

Molecular Cancer Therapeutics

Cancer, COVID and the Kentucky Economy: How 'Sweet Annie' Could Make an Impact

Used as a medicinal herb for centuries, Artemisia annua contains powerful compounds that make it a popular treatment for malaria. But with lab research showing these compounds may help treat a variety of cancers and even COVID-19, this plant is more ...

– University of Kentucky


Three Women Scientists at Johns Hopkins Tapped to Join Exclusive Research Network

Three Johns Hopkins Kimmel Cancer Center scientists are among the first 45 members selected to join the 10x Genomics Visium Clinical Translational Research Network (CTRN), aimed at advancing translational research in some of the world’s leading hea...

– Johns Hopkins Medicine

Hackensack University Medical Center Has the Best Cancer Center in New JerseyJohn Theurer Cancer Center recognized by U.S. News & World Report

U.S. News & World Report has recognized John Theurer Cancer Center at Hackensack University Medical Center as the best cancer center in New Jersey. The recognition reflects the extraordinary strength of its comprehensive patient care, research and ed...

– Hackensack Meridian Health

Memorial Sloan Kettering Awards and Appointments

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

– Memorial Sloan Kettering Cancer Center

Researchers pivot from studying cancer and cystic fibrosis to launch trial of drug to fight COVID-19

The University of Kansas Medical Center announced today a trial exploring a drug intended to fight the cytokine storm common in COVID-19.

– University of Kansas Cancer Center

Embargo expired on 14-Aug-2020 at 09:15 ET

International Mesothelioma Researcher Recognized for Her Work with the National Cancer Institution of Naples and Sbarro Health Research Organization

Held in Locri, Italy on Saturday, August 8 in the enchanting Riviera dei Gelsomini, the Women of Talent Award ceremony recognized the achievements of Francesca Pentimalli, PhD, a frequent collaborator on research with the Sbarro Health Research Organ...

– Sbarro Health Research Organization (SHRO)

2020 Women's Talent Award, Calabria Live; ECO Della Locride, August 8, Cenacle of Culture and Sciences. Women of Talent Award 2020

Chasing the Dream

Ala Ebaid, MD, completed his fellowship in hematology/oncology at the UNM Cancer Center in June and begins clinical work in August. He's been in New Mexico for a decade, and he says he doesn't plan to leave any time soon.

– University of New Mexico Comprehensive Cancer Center

Grant boosts psychosocial care resources during COVID-19 pandemic

The Simms/Mann-UCLA Center for Integrative Oncology has received a $50,000 grant from Los Angeles-based PHASE ONE Foundation to support psychosocial care for people with cancer, their families and frontline healthcare workers during the COVID-19 pand...

– University of California, Los Angeles (UCLA), Health Sciences

Henry Ford Health System Kicks Off David DiChiera Music Therapy Program with Detroit Symphony Orchestra and Michigan Opera Theatre

Henry Ford Health System, in partnership with the Detroit Symphony Orchestra (DSO) and Michigan Opera Theatre (MOT), has begun offering virtual musical performances to cancer patients via its music therapy program named for the founding general direc...

– Henry Ford Health System

Expert Pitch

"Take appropriate precautions," key to protecting lung cancer patients during COVID pandemic, says foundation science director

– GO2 Foundation for Lung Cancer

Patient advocate can comment on the intersection of lung cancer and COVID-19

– GO2 Foundation for Lung Cancer





 Edit My Preferences
 Contact Us
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 American Chemical Society (ACS)

 University of Kentucky

 Michigan Medicine - University of Michigan

 University of Texas M. D. Anderson Cancer Center

 UT Southwestern Medical Center

 Department of Energy, Office of Science

 University of California San Diego Health

 Lund University

 University of California, Los Angeles (UCLA), Health Sciences

Subscribe / Unsubscribe
Edit my preferences

© 2020 Newswise, Inc. All Rights Reserved.

265 Turkey Sag Trail Suite 102, #110 Palmyra VA 22963 | 434-296-9417

 Contact Us